FTLP8

Across TCGA pan-cancer cohorts, FTLP8 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of FTLP8’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where FTLP8 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FTLP8 is over-expressed in tumor, although a few such as KIRP and KICH show the opposite, repressed pattern.

COAD, BRCA, and KIRP are the cancer types where FTLP8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FTLP8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.192	.001	8	view →
BRCA	Female	All	+0.094	.033	2	view →
KIRP	Male	III,IV	−0.175	.049	1	view →
KICH	All	II,III,IV	−0.062	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

FTLP8–COAD

Open the COAD breakdown →